FindTrial
Sign In

Establishment of a Northeast Asian cohort of non-alcoholic fatty liver patients based on liver biopsy

Establishment of a Northeast Asian cohort of non-alcoholic fatty liver patients based on liver biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008787
Enrollment
2500
Registered
2023-09-11
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with non-alcoholic fatty liver disease whose fatty liver and liver fibrosis were clearly evaluated by performing a biopsy will be included between January 1, 1995 and March 31, 2023.

Exclusion criteria

Exclusion criteria: - Patients under the age of 19. - Patients with other liver disease (viral hepatitis, liver cancer, autoimmune liver disease, primary biliary cirrhosis, Wilson's disease, drug-induced hepatitis or liver damage). - Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
Distribution of Fibrosis—

Secondary

MeasureTime frame
Distribution of Fibrosis according to Diabetes and Age—

Countries

Korea, Republic of

Contacts

Public ContactDae Won Jun

Hanyang University

gongori1004@gmail.com+82-2-2290-8334

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026